Un prix Inserm pour les travaux du Professeur nantais Jean-Paul Soulillou
Jean-Paul Soulillou's research works | University of Nantes, Nantes (UNIV Nantes) and other places
An Interview with Jean Dausset
Campus Communication | Flickr
PDF) Dominant Tolerance to Kidney Allografts Induced by Anti-Donor MHC Class II Antibodies: Cooperation between T and Non-T CD103+ Cells
Jean-Paul Soulillou - Scientific Advisor and Co-founder @ Xenothera - Crunchbase Person Profile
Odile DUVAUX - Atlanpole
L'IHU Nantais renforce sa gouvernance médico-scientifique avec la création d'un poste de Directeur général adjoint et la
PDF) Elicited and pre‐existing anti‐Neu5Gc antibodies differentially affect human endothelial cells transcriptome
Greffes : Nantes veut jouer les premiers rôles
JEAN PAUL SOULILLOU - CV - professor
Jean-Paul Soulillou – XENOTHERA
Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection
Cut-Off Estimation and Medical Decision Making Based on a Continuous Prognostic Factor: The Prediction of Kidney Graft Failure
Inserm Announces the Recipients of its 2012 Prizes - Inserm Newsroom
Les coteaux de Bouzic et Florimont vers 1980
Jean-Paul Soulillou: H-index & Awards - Academic Profile | Research.com
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection
CME Slides Forum - J.P. Soulillou
JCI - IL-7 receptor blockade following T cell depletion promotes long-term allograft survival
The Blood of Healthy Individuals Exhibits CD8 T Cells with a Highly Altered TCR Vb Repertoire but with an Unmodified Phenotype
